Cancer is a life-threatening disease which requires timely diagnosis and continuous treatment which is effective. In order to check efficacy of the treatment, there are several tests. Fluid biopsy or fluid phase biopsy, is one such test. It is generally known as liquid biopsy primarily is the sampling and analysis of non-solid biological tissue which is blood. Just like the traditional biopsy, this type of test/ method is primarily used as a tool for diagnosis and tracking level of diseases like cancer. Liquid biopsy is being preferred the most due to its non-invasive nature and are more likely to be used to check efficacy of the treatment with the help of testing several samples that too within the time span of couple of weeks. The global liquid biopsy products market is rampantly growing in wake of numerous factors.

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1372

The coronavirus pandemic has provided impetus to the growth of the global liquid biopsy products market. This was mainly because people suffering from cancer were more likely to be infected with the life-threatening infection. Despite pathology labs being flooded with people to get themselves tested for coronavirus; number of liquid biopsies went up. One of the biggest factor that has been driving the growth of global liquid biopsy products market is increasing prevalence of cancer among people of all ages. Along with this, surging preference for procedures that are non-invasive also help this market grow.

Meanwhile, growing concerns pertaining to low sensitivity and specificity are expected to hinder the growth of the global liquid biopsy products market in the period of forecast. On the other hand, the global liquid biopsy products market is forecasted to witness tremendous growth in coming years due to growing research and development initiatives in the field of medical science.

Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1372

Global Liquid Biopsy Products Market Report Findings:

  • On the basis of application, the non-invasive prenatal tests (NIPT) segment will mint money at the quick speed for the global liquid biopsy products market because growing preference for non-invasive procedures.
  • On the basis of the offering, the services segment that is again bifurcated into custom services and support services will be making major chunk of the money for the global liquid biopsy products market.
  • The region of Asia Pacific is forecasted to mint money at the rapid rate for the global liquid biopsy products market. Densely populated countries like China and India are seeing a surge in the number of cancer patients, specifically young people. This is why the number of people going for liquid biopsy will rise.

View our exclusive press releases on Industry Global News24

  1. Global Biochips Market 2022 – 2030 
  2. Global Peptide Drug Conjugate Clinical Trial Market 2022 – 2030 

Competitors: Global Liquid Biopsy Products Market:

  • Biocept, Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
  • Genomic Health
  • Grail Bio, an Illumina spinoff
  • Guardant Health
  • MDxHealth
  • Pathway Genomics
  • Personal Genome Diagnostics Inc.
  • QIAGEN
  • Other Market Participants

Purchase the latest in-depth Global Liquid Biopsy Products Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1372

Global Liquid Biopsy Products Market

By Application

  • Circulating tumor cells (CTC) in the blood
  • Cell free DNA from tumor or fetus cells (in the blood)
  • Molecular Diagnostics
  • Early Stage Cancer
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Gastric Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Ovarian Cancer
    • Others
  • Non-invasive prenatal tests (NIPT)
  • Others

By Size

  • 5 ml
  • 50 ml
  • 100 ml
  • 250 ml
  • Above 250 ml

By Offering

  • Instruments
    • Blood Collection Tube (BCT) for cfDNA and CTCs
    • Target Selector Kits
    • Cell Free DNA Extraction Kit
    • Cell Free Nucleic Acid Extraction Kit
    • Mutation Quantification Control Plasma
    • Genomic profiling diagnostic kit
    • Target Selector NGS Panels
    • PCR Purification Kit
    • Blood Nucleic Acid Extraction
    • Viral Nucleic Acid Extraction
    • Others
  • Reagents
  • Liquid Biopsy Assays
  • Tools
  • Services
    • Custom Services
    • Support Services
  • Others

By End User

  • Hospitals/ Clinics
  • Pathology Laboratories
  • Physician Laboratories
  • Academic and Research Centers
  • Others

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1372

Top Reports:

Global Breast Biopsy Devices Market – https://www.absolutemarketsinsights.com/reports/Global-Breast-Biopsy-Devices-Market-2022-2030-1338

Global Non-Alcoholic Steatohepatitis Diagnostics Market – https://www.absolutemarketsinsights.com/reports/Global-Non-Alcoholic-Steatohepatitis-Diagnostics-Market-2022-%E2%80%93-2030-1310

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Contact Name: Shreyas Tanna

Company: Absolute Markets Insights

Email Id: sales@absolutemarketsinsights.com

Phone: IN +91-7400-24-24-24, US +1-510-420-1213

Website: www.absolutemarketsinsights.com

Leave a Reply

Your email address will not be published. Required fields are marked *